23 September 2021

GSK Stockmann advises investor on HomeToGo Listing on Frankfurt Stock Exchange

GSK Stockmann advised the investor Princeville Capital involved in the Berlin-based travel start-up HomeToGo on it’s listing on the Frankfurt Stock Exchange via a business combination with Lakestar SPAC.

HomeToGo is an online marketplace with the world’s largest selection of vacation rentals. Lakestar SPAC I SE has been listed as a SPAC on the Frankfurt Stock Exchange since February 2021. Following the successful business combination with HomeToGo and subsequent change of name into HomeToGo SE, the company’s shares have now started trading under ticker symbol HTG (ISIN: LU2290523658) on the Regulated Market (General Standard) of the Frankfurt Stock Exchange.

The transaction was the first signed European De-SPAC with a German target company. Princeville Capital, a leading global growth stage technology investor, is among HomeToGo’s current shareholders. The company, which already worked with Katy Ritzmann in the context of its initial investment in HomeToGo, again had the proven team represent it in this capital markets transaction on the heals of its good experience in connection with the IPO of Auto1 Group SE.

Under the leadership of partner Katy Ritzmann, a GSK Stockmann team advised the investor on all legal matters relating to the business combination with Lakestar SPAC I SE, regulatory matters regarding the listing, as well as tax matters relating to the transaction via the SPAC structure that was done cross-border to Luxembourg. The fully integrated workstreams between GSK Stockmann’s teams in Germany and Luxembourg proved to be of great benefit to Princeville Capital.

Advisors Princeville Capital:

GSK Stockmann: Katy Ritzmann (Lead, Venture Capital), Philipp Mössner (Capital Markets), Heiko Stoll and Mathilde Ostertag (both Tax)

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 05 August 2022

    GSK Update: Amendments to the German Act on Evidence of the Essential Working Conditions

    Read more
  • 25 July 2022

    GSK Update: VAT-exempt management of venture capital funds

    Read more
  • 18 July 2022

    GSK Update: AIFMD review: compromises begin to emerge

    Read more
Contact person

Dr. Katy Ritzmann

Partner*

+49 30 203907-422

katy.ritzmann@gsk.de

* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral